VivoSeq
Other

Brachytherapy

0

Pipeline Programs

7

Active Trials

0

Companies Involved

Brachytherapy is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

16

clinical trials

Completed6 · 38%
Recruiting4 · 25%
Active, not recruiting2 · 13%
Unknown status2 · 13%
Terminated1 · 6%
Not yet recruiting1 · 6%

Trial Activity

16 trials

Brachytherapy for Prostatic Carcinoma Patients
Active, not recruiting·MM.D. Anderson Cancer Center·Phase 2·NCT00525720·300 enrolled
Adjunct Episcleral Brachytherapy for PCV
Not yet recruiting·SSalutaris Medical Devices, Inc.·Phase 3·NCT05251636·159 enrolled
Image-Guided Gynecologic Brachytherapy
Completed··Phase 2·NCT01399658·93 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)